Lan Qian - Profile and Investment Details

Investor Profile

Lan Qian is a Hedge Fund, Venture Capital, Private Equity Firm based in China with a diverse investment portfolio that includes companies such as Berry Genomics, Sagamore Investments, Chengjia Apartment, LifeMine Therapeutics, China Chengxin Credit, Antengene Corporation, Waterdrop, Viela Bio, Yuanfudao, 4Paradigm, D3 Bio, KLOOK, Curon Biopharma, Yatsen Holding, MEGVII, Yimidida, LianLian Pay, NetEase Cloud MusicTrax, Cliffwater LLC, Lalamove, LY.com, J&T Express, Pinduoduo, CStone Pharmaceuticals, iQiyi, Kuaishou Technology, COFCO, Brii Biosciences, Alibaba Group, . Over time, Lan Qian has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Lan Qian is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, E-commerce, Leisure, Wellness, Equities, Investment Management, Infrastructure, Transportation, Apps, Energy, Life Science, Portfolio Management, Education, Artificial Intelligence (AI), Retail, Information Services, Venture Fundraising, Technology, Software, Biotechnology, Construction, Sourcing, Cosmetics, Recreation, Food and Beverage, Courier Service, Logistics, Hedge Funds, Utilities, Market Intelligence, Travel, Renewable Energy, Real Estate, Media and Entertainment, Machine Learning, Pharmaceuticals, Risk Management may find it worthwhile to explore potential connections with Lan Qian, as their portfolio suggests a familiarity and interest in this area.

Understanding Lan Qian’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.